Warren asks HHS watchdog to investigate GSK over its asthma inhaler maneuvers

Taking stock of the drug industry, from the lab to the medicine chest

March 12, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Warren asks HHS watchdog to investigate GSK over its asthma inhaler maneuvers GSK allegedly cost Medicaid nearly $1 billion in 2024 and deterred private insurers from covering a generic of its inhaler, reducing access By Ed Silverman STAT+ | Roche partners with Zealand Pharma to push forward obesity drug With the deal, worth $1.65 billion upfront, the companies will test Zealand's petrelintide on its own and in combination with a Roche drug. By Andrew Joseph How CDC nominee Dave Weldon's support for anti-vaccine theories runs long and deep  The physician and former Florida congressman once urged that immunization review be taken away from the CDC. Now he's set to oversee its vaccine monitoring By Sarah Owermohle

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser